Afriplex is a South African company rooted in the development and manufacturing of botanical extracts, complementary medicines and food & beverage product solutions.

info@afriplex.co.za

+27 (0)21 872 4976

+27 86 578 1305

Trading hours: Monday - Thursday (08:00-17:00) Fridays (08:00-16:30)

Top

Afriplex News

AFRIPLEX ACQUIRES EDELWEISS PHARMACEUTICAL

AFRIPLEX STRENGTHENS ITS POSITION IN THE MARKETPLACE AFTER SUCCESSFUL ACQUISITION! Afriplex is proud to announce that it recently acquired the Edelweiss Pharmaceutical business and is in the process of taking over the manufacturing of all solid dosage forms, namely tablets and capsules. In anticipation of increased business moving into their facility, Afriplex invested in their production plant and staff to ensure they have the infrastructure required to deliver a high level of service and good quality products to both their new and existing clients. Expansions will be completed by the end of February 2017. “Afriplex’s strategy is to maintain leadership in the complementary...

AFRIPLEX-LAUNCHES-APIMF-DEVELOPMENT-PROGRAM

AFRIPLEX LAUNCHES APIMF DEVELOPMENT PROGRAM

Afriplex is excited to announce a unique range of active pharmaceutical ingredients (API), supported by fully developed active pharmaceutical ingredient master files (APIMF). By utilising our research and development capabilities, we've expanded into APIMF development to support our range of API's such as Folicin A/T and Afriplex GRT. An APIMF describes the preparation, control and stability of the API and forms the basis of Module 3.2.S of the Common Technical Document (CTD). An API can be described as the drug substance or the active ingredient of a pharmaceutical product. Afriplex is excited to have launched this program and by working closely with...

THE IMPACT OF AMENDED REGULATIONS ON THE LOCAL CAMS INDUSTRY

Threat or opportunity? Afriplex recently positioned itself to be able to offer unique scientific, technical, legal and regulatory assistance by partnering with strategic role players in the cams industry. This network of experts include regulatory consultants, pharmacists and doctors who are equally passionate about overcoming the challenges associated with the recent legislative changes published into law on 15 november 2013. Recent amendments to the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965) as outlined by the Department of Health (DoH) and Medicines Control Council (MCC) have set new boundaries for the marketing and sales of Complementary and Alternative Medicines...

AFRIPLEX RETURNING TO ITS BOTANICAL ROOTS…

[vc_row css=".vc_custom_1517459872281{padding-bottom: 10px !important;}"][vc_column][vc_column_text] After Aligning Itself With Role-Players In The International Food Supplement Arena, Afriplex Is Returning To Its Roots - Roots That Are Secured By Years Of Experience And Knowledge Of African Botanicals And Extraction Technology. The Company Would Like To Announce That It Will Again Be Supplying Its Well- Established African Botanicals And Extract Range To Its Customers. These Extracts Were Historically Developed For Applications In Various Industries, But With A Strong Focus On Client-Specific Tailoring. Over the past three years Afriplex has expanded its capacity and acquired additional technology, allowing for the production of not only standardized extracts,...

Copyrighted Image